Summary
Malondialdehyde, a marker of lipid peroxidation, was measured as thiobarbituric acid-reactive substance in 78 non-insulin-dependent diabetic patients and 28 healthy subjects. Patients were divided into groups and subgroups according to the presence of microalbuminuria and other complications. Plasma and urine malondialdehyde concentrations were significantly higher in patients with and without microalbuminuria than in controls. In contrast to urine malondialdehyde, plasma malondialdehyde levels were significantly higher in microalbuminuric diabetes than in the nomoalbuminuric diabetic group. There was no correlation between malondialdehyde concentration and glycemic control. This study confirmed the existence of lipid peroxidation disorders in diabetic patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H, Cloarec L. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta 1993; 214:227.
Collier A, Rumley A, Rumley AG, Paterson JR, Leach JP, Lowe GDO, Small M. Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes 1992; 41:909.
Dormandy TL. An approach to free radicals. Lancet 1983; II:1010.
Stringer MD, Görög PG, Freeman A, Kakker W. Lipid peroxides and atherosclerosis. BMJ 1989; 298:281.
Clamp JR, Hartog M, Shelley JH. Carbohydrate containing materials in urine from normal and diabetic subjects. Clin Sci 1979; 56:193.
Baggio B, Briani G, Cicerello E, Gambaro G, Bruttomesso O, Tiengo A, Borsatti A, Crepaldi G. Urinary glycosaminoglycans, sialic acid and lysosomal enzymes increase in nonalbuminuric diabetic patients. Nephron 1986; 43:187.
Mogensen CE. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria. Diabetes 1990; 39:761.
Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; I:1430.
Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem. 1995; 32:303.
Cheung CK, Cockram CS, Yeung VTF, Swaminathan R. Urinary excretion of transferrin by non-insulin-dependent diabetics: a marker for early complications? Clin Chem 1989; 35:1672.
Lyons TS. Oxidized low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes? Diabetes Med 1991; 8:411.
Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnett AH. Increased diene conjugates in diabetic subjects with microangiopathy. Diabetes Med 1987; 4:452.
Jos J, Rybak M, Patin PH, Robert JJ, Boitard C, Thevenin R. Etude des enzymes antioxydantes dans le diabete insulinode’pendant de l’nfant et de l’adolescent (in French). Diabete Metab 1990; 16:492.
National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28:1039.
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95:351.
Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishi N, Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochem Med 1979; 21:104.
Baker JR, Metcalf PA, Johnson RN, Newman D, Rietz P. Use of protein based standards in automated colorimetric determinations of fructosamine in serum. Clin Chem 1985; 31:1550.
Tietz NW, ed. Textbook of clinical chemistry. Philadelphia: Saunders; 1986:786, 805–806, 854, 873–885.
Noberasco G, Odetti P, Boeri D, Maiello M, Adezati L. Malondialdehyde (MDA) level in diabetic subjects. Relationship with blood glucose and glycosylated hemoglobin. Biomed Pharmacother 1991; 45:193.
Altomare E, Vendemiale G, Chicco D, Procacci V, Cirelli F. Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabete Metab 1992; 18:264.
Kaji H, Kurasaki M, Ito K, Saito K, Saito T, Niioka T, Kojima T, Ohsaki Y, Ide H, Tsuji M, Kondo T, Kawakami Y. Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin dependent) diabetic women. Klin Wochenschr 1985; 73:765.
Kitohara M, Eyre HS, Lynch ER, Rollison ML, Hill HR. Metabolic activity of diabetic monocytes. Diabetes 1980; 29:251.
Wohaieb SA, Godin DV. Alterations in free radical tissue—defense mechanism in streptozotocin-induced diabetes in rat. Diabetes 1987; 36:1014.
Dousst JC, Trouilh M, Foglietti MJ. Plasma malonaldehyde levels during myocardial infarction. Clin Chem Acta 1983; 129:319.
Jain SK, McVie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989; 38:1539.
Wolff SP, Dean RT. Glucose autoxidation and potein modification: the potential role of autoxidative glycosylation in diabetes. Biochem J 1987; 245:243.
Carrell RW, Winterbourn CC, Rachmilewitz EA. Activated oxygen and haemolysis. Br J Haematol 1975; 30:259.
Clark IA, Cowden WB, Hunt NH. Free radical-induced pathology. Med Res Rev 1985; 5:297.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Özben, T., Nacitarhan, S. & Tuncer, N. Plasma and urine malondialdehyde levels in non-insulin-dependent diabetic patients with and without microalbuminuria. Int J Clin Lab Res 25, 162–164 (1995). https://doi.org/10.1007/BF02592560
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02592560